|
× |
 |
The Effects of Risperidone on the Five Dimensions of Schizophrenia Derived by Factor Analysis: Combined Results of the North American Trials PDF |
$40.00 |
|
$40.00 |
|
× |
|
Transcranial Magnetic Stimulation in the Acute Treatment of Major Depressive Disorder: Clinical Response in an Open-Label Extension Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Insomnia and Objectively Measured Sleep Disturbances Predict Treatment Outcome in Depressed Patients Treated With Psychotherapy or Psychotherapy-Pharmacotherapy Combinations PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Efficacy and Safety of the Melatonin Agonist beta-Methyl-6-Chloromelatonin in Primary Insomnia: A Randomized, Placebo-Controlled, Crossover Clinical Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Rapid Development of Lorazepam Tolerance Within 48 Hours in an Adult With Intellectual Disability Who Presented With Stuporous Catatonia and Refused Electroconvulsive Therapy PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Abuse of Prescription Medications in Borderline Personality Disorder: A Gender Comparison PDF |
$40.00 |
|
$40.00 |
|
× |
|
Efficacy of Controlled-Release Paroxetine in the Treatment of Late-Life Depression PDF |
$40.00 |
|
$40.00 |
|
|
